Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

The HCP Marketing Pro’s Guide to Digital Healthcare Advertising

August 14, 2024

With the healthcare industry in the midst of a radical transformation, HCP marketing professionals need to find new ways to engage healthcare providers and perfect their digital healthcare advertising.

Top 10 Healthcare Marketing Trends Every Marketer Should Know

August 14, 2024

Whether refining targeting strategies, enhancing patient engagement, or leveraging the latest AI technologies, this article offers valuable insights to help you develop the best marketing plan for your brand.

Strategic Healthcare Marketing Budgeting: Your Complete Guide with Benchmarks

August 14, 2024

Whether you are a healthcare marketing agency developing a healthcare marketing budget for your clients or a pharmaceutical company, medical device manufacturer, or medical practice, understanding the competitive landscape is essential.

6 Ways to Prioritize the Patient Voice in Patient Journey Research

July 29, 2024

In order to execute accurate, dependable, and durable patient journey research, patient voices must serve as the foundation.

HIV Patient-Reported Survey Data

December 7, 2020

New survey data shows 90% of people living with HIV feel controlled on their current treatment plan, but continue to struggle with great challenges.

Cystic Fibrosis Patient-Reported Survey Data

November 24, 2020

Cystic fibrosis survey data reveals that many people living with CF are hopeful and optimistic, yet the future is unknown.

Parkinson’s Disease Patient-Reported Survey Data

November 23, 2020

New Health Union survey data reveals interesting differences in the patient journeys of men and women living with Parkinson’s disease.

Spondyloarthritis Patient-Reported Survey Data

November 18, 2020

Survey data uncovers the often difficult spondyloarthritis diagnosis journey, showing that 83% of respondents with nr-AxSpA were initially misdiagnosed.

Healthcare Industry Thought Leadership

Contact